Our Pricing

Your First Week On Mounjaro: What To Expect

Published on: June 03, 2026

Understanding what to expect during your mounjaro first week what to expect uk journey helps you prepare mentally and physically for this clinically proven weight loss treatment. At Cured Pharmacy, our UK-registered clinical team has guided thousands of patients through their first Mounjaro injection, and we've compiled the most common experiences, practical tips, and realistic expectations for your initial seven days on tirzepatide.

What Happens During Your Mounjaro First Week

Your first Mounjaro injection will be the 2.5mg starter dose, which is specifically designed to help your body adjust to tirzepatide gradually [1]. This initial dose is not intended to produce significant weight loss — it's a tolerance-building phase that minimises side effects whilst allowing the dual GIP/GLP-1 receptor mechanism to begin working.

Most patients report feeling slightly less hungry within 24-48 hours of their first injection, though this varies considerably between individuals [1]. You may notice you feel fuller faster during meals, or that certain foods you previously craved no longer appeal to you as strongly. These are normal responses as tirzepatide begins to regulate your appetite hormones.

It's crucial to understand that the 2.5mg dose is sub-therapeutic for weight loss purposes. In the SURMOUNT-1 trial, participants didn't reach therapeutic doses until after the initial titration period, yet still achieved an average 15-21% body weight reduction over 72 weeks depending on their final maintenance dose [1].

Common Side Effects in Week One

The most frequently reported side effects during your first week on Mounjaro are gastrointestinal in nature, affecting approximately 20-30% of patients at the starter dose [2]. These typically include mild nausea, occasional bloating, and changes in bowel movements. The lower starter dose of 2.5mg is specifically chosen to minimise these effects compared to starting at higher doses.

Nausea, when it occurs, is usually mild and tends to peak 1-3 days after your injection before subsiding. Our superintendent pharmacist Tarun Kumar advises patients to eat smaller, more frequent meals and avoid high-fat foods during this adjustment period. Staying well-hydrated and avoiding lying down immediately after eating can also help manage any digestive discomfort.

Fatigue is another commonly reported experience in week one, affecting roughly 10-15% of patients [2]. This is typically temporary as your body adjusts to the metabolic changes tirzepatide initiates. If you experience persistent or severe side effects, contact your prescriber immediately — they may recommend additional management strategies or, in rare cases, reassess your suitability for treatment.

When to Contact Your Prescriber

Whilst mild side effects are normal, certain symptoms require immediate medical attention. Contact your UK prescriber or seek emergency care if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing you from keeping fluids down, signs of pancreatitis (severe upper abdominal pain radiating to your back), or symptoms of thyroid tumours such as a lump in your neck or difficulty swallowing [2]. These serious side effects are rare but require prompt medical assessment.

Realistic Weight Loss Expectations for Week One

During your first week on the 2.5mg starter dose, most patients lose between 0-2 pounds, with some experiencing no weight loss at all [3]. This is completely normal and expected — the starter dose is designed for tolerance building, not rapid weight loss. Patients who lose more than this in week one are often experiencing water weight fluctuations rather than true fat loss.

Clinical trial data shows that meaningful weight loss typically begins after patients reach the 5mg dose or higher, which occurs after at least 4-8 weeks of gradual dose escalation [3]. The SURMOUNT-1 trial demonstrated that patients on the highest maintenance dose (15mg) achieved an average 20.9% body weight reduction over 72 weeks, but this was a gradual process with most weight loss occurring after the titration phase [1].

Setting realistic expectations is crucial for treatment adherence. Patients who expect dramatic results in week one often feel discouraged unnecessarily. Remember that Mounjaro is a long-term treatment programme, and the clinical trials that demonstrated such impressive results measured outcomes over 18 months, not one week.

How to Administer Your First Mounjaro Injection

Mounjaro comes as a pre-filled KwikPen that's designed for ease of use, even for injection-naive patients. Before your first injection, remove the pen from the refrigerator and allow it to reach room temperature for 30 minutes — cold injections can be more uncomfortable. Wash your hands thoroughly and choose an injection site on your abdomen (at least 2 inches from your belly button), thigh, or upper arm.

Clean the injection site with an alcohol wipe and allow it to dry completely. Remove the pen cap, place the pen firmly against your skin at a 90-degree angle, and press the injection button. You'll hear a click, and you must hold the pen in place for 10 seconds to ensure you receive the full dose [4]. A second click indicates the injection is complete. Dispose of the used pen in a sharps container — never reuse Mounjaro pens.

Rotate your injection sites each week to prevent lipodystrophy (changes in fat tissue under the skin). If you inject on Monday evenings, for example, keep this same day and approximate time each week for consistent blood levels. The pen can be stored in the refrigerator between 2-8°C, but never freeze it. Once in use, a Mounjaro pen can be kept at room temperature (below 30°C) for up to 21 days [4].

Injection Tips from Our Clinical Team

Our UK prescribers recommend these practical tips for a more comfortable first injection: pinch the skin gently to create a small fold before injecting, exhale slowly as you press the button, and apply gentle pressure with a clean cotton pad afterwards if needed. If you're particularly needle-anxious, applying an ice pack to the area for 30 seconds before injection can provide mild numbing. Most patients report that their anxiety about injecting decreases significantly after the first successful administration.

Dietary and Lifestyle Adjustments for Week One

During your first week on Mounjaro, focus on eating smaller, protein-rich meals rather than attempting dramatic dietary changes. Tirzepatide naturally reduces your appetite, so forcing yourself to eat large portions can trigger nausea. Aim for 3 small meals and 1-2 snacks daily, prioritising lean proteins, vegetables, and whole grains whilst moderating high-fat and highly processed foods.

Hydration becomes particularly important on Mounjaro, as reduced appetite can sometimes lead to decreased fluid intake. Aim for at least 2 litres of water daily, and consider setting hourly reminders if you're not naturally thirsty. Adequate hydration helps prevent constipation (a common side effect) and supports the metabolic processes involved in weight loss [5].

Gentle physical activity is encouraged from day one, but this isn't the week to start an intense new exercise programme. A 20-30 minute daily walk is ideal for most patients, providing cardiovascular benefits without overtaxing your body during the adjustment period. As you progress to higher doses and begin losing weight, you can gradually increase exercise intensity under guidance from your healthcare team.

What to Expect in Weeks 2-4 and Beyond

After completing your first week, you'll continue on the 2.5mg dose for a total of 4 weeks before your prescriber reviews your tolerance and potentially increases you to 5mg [1]. This gradual titration schedule is evidence-based and designed to optimise both efficacy and tolerability. Each dose increase requires at least 4 weeks at the current level, allowing your body to fully adapt.

Most patients begin noticing more significant appetite suppression and early weight loss when they reach the 5mg or 7.5mg doses, typically around weeks 5-12 of treatment [3]. The maintenance doses (10mg, 12.5mg, or 15mg) are where the most substantial weight loss occurs, with clinical trials showing average reductions of 15-21% of baseline body weight over 72 weeks depending on the final dose achieved [1].

At Cured Pharmacy, Mounjaro is available from £124.99 with transparent upfront pricing and free clinical consultations completed in under 3 minutes. All prescriptions are issued by UK-registered prescribers following a thorough medical assessment, and we dispense only genuine UK-licensed medications. Your treatment journey includes ongoing support from our clinical team, with regular check-ins to monitor your progress and adjust your dose as appropriate.

Comparing Mounjaro to Alternative Weight Loss Treatments

Whilst Mounjaro has demonstrated superior weight loss outcomes in head-to-head trials, other treatments may be more suitable depending on your medical history, budget, and preferences. Wegovy (semaglutide) is another once-weekly injectable that works through a single GLP-1 pathway and has shown average weight loss of 15% in clinical trials [6]. Saxenda (liraglutide) requires daily injections but may suit patients who prefer more frequent dosing with a shorter-acting medication. Your UK prescriber will discuss all licensed options during your consultation to determine the most appropriate treatment for your individual circumstances.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
3. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on glycaemic control and body weight in participants with type 2 diabetes mellitus and obesity: SURPASS-4 extension study. Diabetes, Obesity and Metabolism, 25(4), 1135–1145. https://doi.org/10.1111/dom.14967 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes: Technology appraisal guidance [TA924]. NICE. https://www.nice.org.uk/guidance/ta924 [accessed 13 August 2026]
5. Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725 [accessed 13 August 2026]
6. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and individual results may vary. Side effects can occur — read the patient information leaflet carefully and report any concerns to your prescriber.